|
Q3 FY2026
As of May 31, 2026
|
Q2 FY2026
As of Feb 28, 2026
|
Q1 FY2026
As of Nov 30, 2025
|
Q4 FY2025
As of Aug 31, 2025
|
Q3 FY2025
As of May 31, 2025
|
Q2 FY2025
As of Feb 28, 2025
|
Q1 FY2025
As of Nov 30, 2024
|
Q4 FY2024
As of Aug 31, 2024
|
Q3 FY2024
As of May 31, 2024
|
Q2 FY2024
As of Feb 29, 2024
|
Q1 FY2024
As of Nov 30, 2023
|
Q4 FY2023
As of Aug 31, 2023
|
Q3 FY2023
As of May 31, 2023
|
Q2 FY2023
As of Feb 28, 2023
|
Q1 FY2023
As of Nov 30, 2022
|
Q4 FY2022
As of Aug 31, 2022
|
Q3 FY2022
As of May 31, 2022
|
Q2 FY2022
As of Feb 28, 2022
|
Q1 FY2022
As of Nov 30, 2021
|
Q4 FY2021
As of Aug 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Marketable securities | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Non-current assets, net | ||||||||||||||||||||
| Long-term receivables | ||||||||||||||||||||
| Right of use assets | ||||||||||||||||||||
| Intellectual property, net | ||||||||||||||||||||
| Property & equipment, net | ||||||||||||||||||||
| Total Non-current Assets | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Lease liabilities | ||||||||||||||||||||
| Lease liability, current | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Lease liability, current | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Lease liabilities - non-current | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| Share Capital | ||||||||||||||||||||
| Authorized: 220,000,000 common voting shares with a par value of $0.001 per share Common shares issued and outstanding: 24,787,446 and 19,559,179 at May 31, 2026 and August 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated Deficit | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Equity attributable to shareholders of Lexaria | ||||||||||||||||||||
| Non-controlling Interest | ||||||||||||||||||||
| Non-controlling Interest | ||||||||||||||||||||
| Total Stockholders' Equity | ||||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
Loading...
